Replagal Enzyme Replacement Therapy for Children With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fabry Disease
Related studies linked through entity extraction aliases.
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE4
Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE4
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Fabrazyme in Pediatric Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dosing Study of Replagal in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Registry of Fabry Disease - A Multicenter Observational Study
- Status
- COMPLETED
- Phase
- N/A
Alpha-Galactosidase A Replacement Therapy for Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Data Collection in Women With Fabry Disease
- Status
- COMPLETED
- Phase
- N/A
PET Scans in Normal Volunteers and Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- N/A
Vasodilation in Patients With Fabry's Disease
- Status
- COMPLETED
- Phase
- N/A